NTGN - Neon Therapeutics +18.6% amid journal publication September, 05 2019 05:31 PM Neon Therapeutics Inc. Neon Therapeutics (NASDAQ:NTGN) is up 18.6% postmarket after announcing publication in the journal Immunity of a proprietary class II prediction approach.More news on: Neon Therapeutics, Inc., Healthcare stocks news, Stocks on the move, Read more ...